Now considered a landmark in the GLP-1 field, the article listed Mojsov as the first author and Habener as the last, a position customarily reserved for the senior author (Couzin-Frankel 8 Sept 2023
Semaglutide may worsen diabetic retinopathy in some patients with pre-existing disease, particularly during rapid improvement in glucose control
Figure 17: Photograph of Professor Viktor Mutt (1923-1998) standing next to Sephadex column
In our practice at Lite Medical, the reasons for discontinuing Semaglutide , Tirzepatide or other GLP-1 medications generally fall into three common categories: Access and Affordability: The most frequent reason is often related to changes in insurance coverage
Aroda VR, Blonde L, Pratley RE
BelaunzaranZamudio at the National Institute of Allergy and Infectious Diseases